JP2024516962A5 - - Google Patents
Info
- Publication number
- JP2024516962A5 JP2024516962A5 JP2023563876A JP2023563876A JP2024516962A5 JP 2024516962 A5 JP2024516962 A5 JP 2024516962A5 JP 2023563876 A JP2023563876 A JP 2023563876A JP 2023563876 A JP2023563876 A JP 2023563876A JP 2024516962 A5 JP2024516962 A5 JP 2024516962A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- fab
- amino acid
- acid sequence
- sequence described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21169183 | 2021-04-19 | ||
| EP21169183.7 | 2021-04-19 | ||
| PCT/EP2022/060236 WO2022223514A1 (en) | 2021-04-19 | 2022-04-19 | An anti-tslp fab with improved stability |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516962A JP2024516962A (ja) | 2024-04-18 |
| JP2024516962A5 true JP2024516962A5 (https=) | 2025-05-16 |
Family
ID=75588042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023563876A Pending JP2024516962A (ja) | 2021-04-19 | 2022-04-19 | 安定性が改善された抗ＴＳＬＰ Ｆａｂ |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20240199730A1 (https=) |
| EP (1) | EP4326767A1 (https=) |
| JP (1) | JP2024516962A (https=) |
| KR (1) | KR20230172508A (https=) |
| CN (1) | CN117222665A (https=) |
| AR (1) | AR125379A1 (https=) |
| AU (1) | AU2022263281A1 (https=) |
| BR (1) | BR112023021587A2 (https=) |
| CA (1) | CA3216894A1 (https=) |
| CL (1) | CL2023003082A1 (https=) |
| CO (1) | CO2023015286A2 (https=) |
| CR (1) | CR20230533A (https=) |
| EC (1) | ECSP23086870A (https=) |
| IL (1) | IL307651A (https=) |
| MX (1) | MX2023012266A (https=) |
| PH (1) | PH12023552762A1 (https=) |
| SA (1) | SA523451188B1 (https=) |
| TW (1) | TW202306982A (https=) |
| WO (1) | WO2022223514A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12022551022A1 (en) * | 2019-10-28 | 2023-03-06 | Medimmune Ltd | Dry powder formulations of thymic stromal lymphopoietin (tslp)-binding antibodies and methods of use thereof |
| US12110324B2 (en) | 2022-07-22 | 2024-10-08 | Flagship Pioneering Innovations Vi, Llc | Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP) |
| TW202529811A (zh) | 2024-01-29 | 2025-08-01 | 瑞典商阿斯特捷利康公司 | 胸腺基質淋巴細胞生成素（ｔｓｌｐ）結合片段之組成物及其使用方法 |
| US20260034317A1 (en) | 2024-05-20 | 2026-02-05 | Medimmune Limited | Inhaler and capsule for delivering thymic stromal lymphopoietin (tslp)-binding antibodies |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001297872B2 (en) | 2000-11-17 | 2006-11-09 | University Of Rochester | In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
| WO2002096948A2 (en) | 2001-01-29 | 2002-12-05 | Idec Pharmaceuticals Corporation | Engineered tetravalent antibodies and methods of use |
| KR102666879B1 (ko) * | 2017-04-12 | 2024-05-23 | 암젠 인크 | 항-tslp 항체를 이용한 천식의 치료 |
| EP4025602A4 (en) * | 2019-09-04 | 2023-12-13 | Biosion, Inc. | TSLP BINDING ANTIBODIES AND USES THEREOF |
| PH12022551022A1 (en) * | 2019-10-28 | 2023-03-06 | Medimmune Ltd | Dry powder formulations of thymic stromal lymphopoietin (tslp)-binding antibodies and methods of use thereof |
-
2022
- 2022-04-19 PH PH1/2023/552762A patent/PH12023552762A1/en unknown
- 2022-04-19 BR BR112023021587A patent/BR112023021587A2/pt unknown
- 2022-04-19 CN CN202280029099.0A patent/CN117222665A/zh active Pending
- 2022-04-19 WO PCT/EP2022/060236 patent/WO2022223514A1/en not_active Ceased
- 2022-04-19 IL IL307651A patent/IL307651A/en unknown
- 2022-04-19 KR KR1020237038201A patent/KR20230172508A/ko active Pending
- 2022-04-19 CR CR20230533A patent/CR20230533A/es unknown
- 2022-04-19 TW TW111114769A patent/TW202306982A/zh unknown
- 2022-04-19 JP JP2023563876A patent/JP2024516962A/ja active Pending
- 2022-04-19 EP EP22724429.0A patent/EP4326767A1/en active Pending
- 2022-04-19 US US18/287,240 patent/US20240199730A1/en active Pending
- 2022-04-19 AU AU2022263281A patent/AU2022263281A1/en active Pending
- 2022-04-19 CA CA3216894A patent/CA3216894A1/en active Pending
- 2022-04-19 AR ARP220101003A patent/AR125379A1/es unknown
- 2022-04-19 MX MX2023012266A patent/MX2023012266A/es unknown
-
2023
- 2023-10-17 CL CL2023003082A patent/CL2023003082A1/es unknown
- 2023-10-18 SA SA523451188A patent/SA523451188B1/ar unknown
- 2023-11-14 CO CONC2023/0015286A patent/CO2023015286A2/es unknown
- 2023-11-16 EC ECSENADI202386870A patent/ECSP23086870A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024516962A5 (https=) | ||
| WO2025081540A1 (zh) | 抑制PCSK9基因表达的siRNA的制备方法 | |
| CN106086102B (zh) | 一种生产反式-4-羟基-l-脯氨酸的工程菌及其构建方法与应用 | |
| CN109970858B (zh) | Cd22单域抗体、核苷酸序列及试剂盒 | |
| CN111139230A (zh) | 一种L-苏氨酸醛缩酶突变体、基因及制备L-syn-对甲砜基苯丝氨酸的方法 | |
| KR20180011313A (ko) | 정제 화학약품의 개선된 제조를 위한 재조합 미생물 | |
| WO2015158213A1 (zh) | 一种具有高转糖苷活性的β-半乳糖苷酶突变体及其制备方法和应用 | |
| CN113754726B (zh) | 一种含多肽标签的重组酶及其在医药化学品合成中的应用 | |
| Kefala et al. | Structures of the OmpF porin crystallized in the presence of foscholine‐12 | |
| CN105647912A (zh) | 抗酸表达盒及其筛选方法 | |
| JPWO2023282161A5 (https=) | ||
| JP2023171909A5 (https=) | ||
| CN115043933B (zh) | 靶向新冠病毒的纳米抗体及其制备方法和应用 | |
| CN117486982B (zh) | 转运蛋白TdcC在提高L-肌肽的产量中的应用 | |
| CN116574750B (zh) | 一种提高腈类化合物生物转化效率的腈水合酶重组质粒及其构建方法与应用 | |
| JP2001340091A (ja) | アミド化合物の製造方法 | |
| JP2015536347A5 (https=) | ||
| CN102241759A (zh) | 一种抑菌性铁蛋白及其制备和应用 | |
| CN102965376B (zh) | 一种 n-(3-氧化十二烷酰基)-l-同型丝氨酸内酯核酸适体及其筛选方法和应用 | |
| CN104474557A (zh) | 一种具有抑菌活性的长牡蛎C型凝集素-2(CgCLec-2)重组蛋白的应用 | |
| WO2026011786A1 (zh) | 一种Patisiran的制备方法 | |
| JP2024523166A5 (https=) | ||
| WO2026011783A1 (zh) | 一种Givosiran的制备方法 | |
| WO2026011787A1 (zh) | 一种qpi-1002的制备方法 | |
| WO2026011779A1 (zh) | 制备Cemdisiran的方法 |